Loading clinical trials...
Loading clinical trials...
Molar-Incisor Hypomineralization (MIH) is a qualitative developmental defect of enamel primarily affecting the permanent first molars and often incisors. The global prevalence of MIH ranges from 2.9% ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Marmara University
NCT07452614 · Pulp Disease, Dental, Pulpitis, and more
NCT07436039 · Molar-Incisor Hypomineralization (MIH)
NCT07283744 · Stress (Psychology), Inflamation, and more
NCT06207253 · Endodontic Disease, Pulp Disease, Dental, and more
NCT06959043 · Type 2 Diabetes Mellitus (T2DM), Insulin Resistance, and more
Marmara Üniversitesi Recep Tayyip Erdoğan Külliyesi Sağlık Yerleşkesi, Diş Hekimliği Fakültesi, Başıbüyük Yolu 9/3 34854 Başıbüyük / Maltepe / İSTANBUL
Istanbul, Beypazarı
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions